Skip to content
The Nexus
DossierENTITY

Sara Narcross

Coverage of Sara Narcross in the Nexus archive.

Earliest in view: Jul 20 · 12:52 UTCMost recent: Jul 20 · 12:52 UTC
Co-mentioned in this coverage
Novo Nordiskorganization1Ozempictopic1South Africaplace1obesitytopic1counterfeit productstopic1diabetestopic1
Recent coverage
  • HEALTHJul 20 · 12:52 UTCSEMAFOR
    Novo Nordisk launches cheaper Ozempic in South Africa

    Novo Nordisk launched a cheaper version of its weight-loss drug Ozempic in South Africa to combat counterfeit products and address high obesity rates. The drug, originally developed for diabetes, is now in high demand, with unregulated alternatives flooding the market due to affordability issues. South Africa has the highest adult obesity rate in Africa, affecting nearly 30% of adults, with women disproportionately impacted.

Sara Narcross · Dossier · The Nexus